Chemerin is not associated with subclinical atherosclerosis markers in prediabetes and diabetes

Aydin K., CANPOLAT U., Akin S., Dural M., Karakaya J., AYTEMİR K., ...Daha Fazla

ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.16, sa.10, ss.749-755, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 16 Sayı: 10
  • Basım Tarihi: 2016
  • Doi Numarası: 10.5152/anatoljcardiol.2015.6629
  • Dergi Adı: ANATOLIAN JOURNAL OF CARDIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.749-755
  • Anahtar Kelimeler: chemerin, diabetes, pulse wave velocity, atherosclerosis, carotid plaque, epicardial fat, EPICARDIAL ADIPOSE-TISSUE, ARTERIAL STIFFNESS, METABOLIC SYNDROME, CORONARY ATHEROSCLEROSIS, CARDIOVASCULAR MORTALITY, ENDOTHELIAL DYSFUNCTION, HYPERTENSIVE PATIENTS, CLINICAL-APPLICATIONS, INSULIN-RESISTANCE, AORTIC STIFFNESS
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Objective: Chemerin is a novel adipokine that is correlated with adipocyte differentiation, glucose metabolism, and inflammation. We aimed to investigate the relation between serum chemerin level and subclinical atherosclerosis markers as exemplified by brachial artery pulse wave velocity (baPWV), carotid intima-media thickness (CIMT), epicardial fat thickness (EFT), and carotid plaque presence in diabetes and prediabetes.